High Throughput Screening (HTS): Market Research Report

Date: January 9, 2017
Pages: 339
Price:
US$ 4,500.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: HEFC94AC1ACEN
Leaflet:

Download PDF Leaflet

High Throughput Screening (HTS): Market Research Report
This report analyzes the worldwide markets for High Throughput Screening (HTS) in US$ Million. The Global market is further analyzed by the following Product Segments and Technology Types - Product Segments: Consumables/Reagents, Instruments, and Software and Services; and Technology Types: Label-Free Technology, Cell-Based Assay, and Others.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 104 companies including many key and niche players such as -
  • Agilent Technologies, Inc.
  • Aurora Biomed, Inc.
  • Axxam SpA
  • BD Biosciences
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Product Types
Consumables/Reagents
Instruments
Software
Services
Technology Types
Label-Free Technology
Cell-Based Assay
Others

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

High Throughput Screening (HTS): A Prelude
HTS: The Mainstream Technology for Drug Discovery Programs
Unparalleled Advantages in Compound Screening Drives Wider Adoption
Key Benefits of HTS – An Overview
Investigate Vast Number of Modulators
Accelerated Target Interrogation
Generate Highly Relevant Data for Latter Stage Screening
Scaling Efficiency
Reduced Costs
Soaring R&D Spending Creates Conducive Environment for HTS

Table 1. Healthcare Spending as a Percentage (%) of National GDP for Select Developed Nations (2014) (includes corresponding Graph/Chart)
Table 2. Healthcare Spending as a Percentage (%) of National GDP for Select Developing Nations (2014) (includes corresponding Graph/Chart)


Shift towards High Throughput Research Builds Momentum for HTS
Upward Trajectory in Med Tech Sector Generates Parallel Opportunities
Stable Economic Outlook to Keep Market Sentiment Intact in the Near Term

Table 3. World Real GDP Growth Rates in % (2016-2018P): Breakdown by Country/Region (includes corresponding Graph/Chart)


Developed Regions: Key Revenue Contributors
HTS Adoption Continues to Expand in Developing Regions
Key Factors Driving Demand for HTS in the Developing Regions
Rising Healthcare and R&D Spending
Uptrend in Pharmaceutical, Biotech & CRO Sectors
Competitive Scenario
Leading Players in the World HTS Market
M&A Activity
Select M&A Deals in the HTS Domain (2014-2017)

2. KEY MARKET TRENDS & GROWTH DRIVERS

Cell-based Assay: The Widely Used HTS Technology
Resolving Technical Limitations: Cornerstone for Future Success of Cell-based HTS
HTS Aims to Expand Use Case in Biochemical Applications
Label-Free HTS Demonstrates Fastest Growth
Lab-on-a-Chip HTS Seeks to Proliferate the Market
Bioinformatics HTS Enhanced with Computational Algorithms
Positive Prognosis across End-Use Markets to Underpin Revenue Growth

Table 4. Global High Throughput Screening Market by End-Use Sector (2016): Percentage Breakdown of Revenues for Academia, Biotechnology, Contract Research Organizations (CROs), Government R&D, Pharmaceutical and Other Sectors (includes corresponding Graph/Chart)


Pharmaceutical Industry Leads the Way
HTS Deployments Soar in Academia
Progressive Advancements in HTS Instruments Accelerate Market Growth
Microplate Handling Systems: An Important HTS Instrument Type
Microplates
Microplate Readers
Liquid Handling Devices: A Necessity in HTS Processes
Microscopic Systems Facilitate Seamless Quantitative Analysis
Advanced Software Platforms Augment HTS Proficiency
Services: An Important Revenue Generating Segment
Expansion in Compound Libraries Widens Functional Scope of HTS
Compound Libraries Facilitate Simultaneous Functional Genomics & Small Molecule Analysis
Laboratory Automation & Miniaturization Spell Opportunities for HTS
Miniaturization of Compound Screening Processes Drives Demand for HTS
HTS Miniaturization – Technology Developments
HTS Robotics Support Miniaturization
IVC – A Miniaturized, Powerful HTS Technology
HTS Assumes Critical Importance in Target Identification & Validation
HTS Gathers Steam in Primary Screening Applications
HTS Perceives Bright Future in Stem Cell Research
HTS in Kinase Inhibitors Identification
HTS in Alzheimer’s Disease Drug Discovery
HTS for Less Simplified PCR Systems
HTFC Eases Metabolic Activity Analysis for Pharmaceutical Drugs
Open Access Platforms Widen HTS Audience Base
Need for Stringent QA System to Keep Failures at Bay
High Throughput Screening (HTS) Vs. High Content Screening (HCS)
Rise in Adoption of HCS Technology in HTS Laboratories

3. PRODUCT OVERVIEW

High Throughput Research (HTR)
High Throughput Screening (HTS)
HTS Product Types
Consumables/Reagents
Instruments
Software
Services
HTS Technologies
Label-Free Technology
Cell-Based Assay
Others
HTS Process: An Overview
Functional and Non-Functional – Two Types of High Throughput Assays
HTS: A Historical Perspective

4. DRUG DISCOVERY – AN OVERVIEW

Drug Discovery – Definition
Drug Discovery Process
Drug Discovery Technologies
Computer Aided Drug Discovery (CADD)
The Evolution of Computer Aided Drug Discovery (CADD) Processes
High Throughput Screening
Virtual Screening
Cloud Computing
Hit and Lead Generation Strategies
Different Stages in Hit and Lead Generation
From ‘Hit’ to ‘Lead’ in HTS – A Complex Endeavor

5. PRODUCT/SERVICE LAUNCHES

Bio-Rad and Illumina Unveil Illumina Bio-Rad Single-Cell Sequencing Solution
DiscoverX Unveils PathHunter Checkpoint Receptor Screening & Profiling Services
Roche Launches cobas CT/NG for cobas 6800/8800 Systems
PerkinElmer Introduces Vectra Polaris Automated Quantitative Pathology Imaging System
Bruker Rolls Out MALDI PharmaPulse 2.
Genedata Unveils New Solution for High-Throughput Automated Patch Clamp Experiments
Genedata Unveils Genedata Screener Version
BD Rolls Out BD CLiC System
Molecular Devices Unveils Upgraded Version of MetaXpress High-Content Image Acquisition and Analysis Software
Crown Bioscience Unveils Huscreen High Throughput Oncology Service Platform
Catalent Pharma Solutions Extends OptiForm Solution Suite for Macromolecule Rapid Screening
OptraSCAN Unveils Subscription Scheme for High Throughput Whole Slide Imaging
Core Informatics Unveils New Applications for Therapeutic Biologics Discovery & Development
Horizon Discovery Introduces New High Throughput Platform for Immuno-Oncology Research
Bruker Unveils MALDI PharmaPulse HTS Platform
BellBrook Labs Launches TR-FRET Version of Transcreener UDP HTS Assay

6. RECENT INDUSTRY ACTIVITY

Eurofins Pharma Discovery Services Acquires DiscoverX
Sartorius Group Acquires Essen BioScience
Evotec and MaRS Innovation Establish Fibrocor Therapeutics
Axxam Joins PHAGO Project
Charles River to Expand Bioactivity Testing Lab Capacities in Germany
Evotec Teams Up with Asahi Kasei Pharma
PerkinElmer to Take Over Euroimmun Medical Laboratory Diagnostics
Evotec Takes Over Aptuit
STORM Therapeutics Partners with Evotec
TTP Labtech Teams Up with Genedata
Pluriomics Collaborates with Pivot Park Screening Centre
PerkinElmer to Acquire Tulip Diagnostics
Sartorius Takes Over IntelliCyt
Thermo Fisher Scientific Acquires Affymetrix
Thermo Fisher Scientific Snaps Up FEI Company
Tecan Group Takes Over SPEware
Evotec Selects Genedata Screener for its HTS Unit
Evotec Snaps Up Cyprotex
AstraZeneca Collaborates with IntelliCyt
Massachusetts General Hospital Teams Up with IntelliCyt
Twist Bioscience Expands Collaboration with Ginkgo Bioworks
Icagen Acquires Ultra High-Throughput Assets of Sanofi
Albany Molecular Research and New York Center for Nanomedicine Research Team Up
Genedata Extends License Deal with Ono Pharmaceutical
IDBS and Cancer Research Technology Team Up
PerkinElmer Acquires Vanadis Diagnostics
Aptuit Acquires Exquiron Biotech
BGI Selects Solvay’s KetaSpire PEEK for its BGISEQ-500 HTS System
Novogene and AITbiotech to Establish NovogeneAIT Genomics Singapore
Teva Pharmaceutical Industries Collaborates with AbCellera
Merck Acquires Sigma-Aldrich
JEOL USA Teams Up with IMRI
CIRCE Teams Up with Freeslate
Dow AgroSciences Inks License Agreement with Critical Path Services
TMG Collaborates with Verdeca
Albany Molecular Research Signs Collaborative Agreement with Multispan
Cyprotex Inaugurates New HTS Laboratory in the US
The Institut Pasteur Inks Partnership Agreement with IntegraGen
Charles River Laboratories Acquires Oncotest
Exquiron Inks Partnership Agreement with SAMDI Tech
Vaccinogen Inks Option Agreement with Dublin City University

7. FOCUS ON SELECT GLOBAL PLAYERS

Agilent Technologies, Inc. (USA)
Aurora Biomed, Inc. (Canada)
Axxam SpA (Italy)
BD Biosciences (USA)
Danaher Corporation (USA)
Beckman Coulter, Inc. (USA)
Molecular Devices Inc. (USA)
Pall ForteBio LLC (USA)
Bio-Rad Laboratories, Inc. (USA)
BioTek Instruments Inc. (USA)
BMG LABTECH GmbH (Germany)
Charles River Laboratories International, Inc. (USA)
Corning Inc. (USA)
DiscoveRx Corporation (USA)
Evotec AG (Germany)
F. Hoffmann-La Roche Ltd. (Switzerland)
Genedata AG (Switzerland)
IntelliCyt Corporation (USA)
Luminex Corporation (USA)
PerkinElmer, Inc. (USA)
Sigma-Aldrich Corp. (USA)
Tecan Group Ltd. (Switzerland)
Thermo Fisher Scientific Inc. (USA)

8. GLOBAL MARKET PERSPECTIVE

Table 5. World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 6. World Historic Review for High Throughput Screening (HTS) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 7. World 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
Table 8. World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments, and Other Products Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 9. World Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/ Reagents, Instruments, and Other Products Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 10. World 14-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Revenues for Consumables/Reagents, Instruments, and Other Products Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
Table 11. World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Technology Type - Label-Free Technology, Cell-Based Assay, and Other Technology Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 12. World Historic Review for High Throughput Screening (HTS) by Technology Type - Label-Free Technology, Cell-Based Assay, and Other Technology Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 13. World 14-Year Perspective for High Throughput Screening (HTS) by Technology Type - Percentage Breakdown of Revenues for Label-Free Technology, Cell-Based Assay, and Other Technology Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Market Overview
HTS Assumes Critical Importance in Drug Discovery Projects
Spending on HTS Soars in Pharmaceutical Sector
Cell-Based Assays Gain Popularity
HTS Outsourcing Gathers Steam
Product/Service Launches
Strategic Corporate Developments
Key Players
B. Market Analytics

Table 14. US Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 15. US Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Outlook
Strategic Corporate Development
Key Player
B. Market Analytics

Table 16. Canadian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 17. Canadian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Outlook
Strategic Corporate Development
B. Market Analytics

Table 18. Japanese Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 19. Japanese Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Outlook
Market Shifts Towards Maturity – Technological Innovations Come to the Rescue
HTS in European Pharmaceutical Industry
Clinical Trials Market in Europe
Innovations in Cell Culture Drive Adoption of Cell-based Assay HTS
Label-Free Technologies Aim to Penetrate the Market
B. Market Analytics

Table 20. European Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 21. European Historic Review for High Throughput Screening (HTS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 22. European 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4A. FRANCE

A. Market Analysis
Outlook
Strategic Corporate Development
B. Market Analytics

Table 23. French Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 24. French Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Outlook
Strategic Corporate Developments
Key Players
B. Market Analytics

Table 25. German Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 26. German Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4C. ITALY

A. Market Analysis
Outlook
Strategic Corporate Development
Key Player
B. Market Analytics

Table 27. Italian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 28. Italian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Outlook
Product/Service Launch
Strategic Corporate Developments
B. Market Analytics

Table 29. The UK Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 30. The UK Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4E. SPAIN

Market Analysis

Table 31. Spanish Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 32. Spanish Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4F. RUSSIA

Market Analysis

Table 33. Russian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 34. Russian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4G. REST OF EUROPE

A. Market Analysis
Outlook
Product/Service Launches
Strategic Corporate Developments
Key Players
B. Market Analytics

Table 35. Rest of Europe Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 36. Rest of Europe Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Asia-Pacific Emerges as Fastest Growing Market for HTS
Pharmaceutical & Biotech Industries Lead the Way
B. Market Analytics

Table 37. Asia-Pacific Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 38. Asia-Pacific Historic Review for High Throughput Screening (HTS) by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 39. Asia-Pacific 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

5A. CHINA

A. Market Analysis
Outlook
Opportunities in Expanding in the Chinese Life Sciences Sector
Growing Drug Discovery Outsourcing Market Bodes Well for Market
Few Problem Areas Exist…
What Outsourcers Need to Look Forward to…
Strategic Corporate Development
B. Market Analytics

Table 40. Chinese Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 41. Chinese Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5B. INDIA

A. Market Analysis
Market Overview
HTS Seeks Role in Indian Pharmaceutical Industry
Strategic Corporate Development
B. Market Analytics

Table 42. Indian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 43. Indian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5C. REST OF ASIA-PACIFIC

A. Market Analysis
Outlook
Strategic Corporate Development
B. Market Analytics

Table 44. Rest of Asia-Pacific Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 45. Rest of Asia-Pacific Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

6. LATIN AMERICA

Market Analysis

Table 46. Latin American Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 47. Latin American Historic Review for High Throughput Screening (HTS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 48. Latin American 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin America Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

6A. BRAZIL

Market Analysis

Table 49. Brazilian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 50. Brazilian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

6B. REST OF LATIN AMERICA

Market Analysis

Table 51. Rest of Latin America Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 52. Rest of Latin America Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

7. REST OF WORLD

A. Market Analysis
Outlook
Strategic Corporate Development
B. Market Analytics

Table 53. Rest of World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 54. Rest of World Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 104 (including Divisions/Subsidiaries - 107)
The United States (64)
Canada (2)
Japan (2)
Europe (34)
  France (4)
  Germany (7)
  The United Kingdom (10)
  Italy (1)
  Spain (1)
  Rest of Europe (11)
Asia-Pacific (Excluding Japan) (5)
Skip to top


Ask Your Question

High Throughput Screening (HTS): Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: